⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Artiva Biotherapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Artiva Biotherapeutics
↗San Diego, USA
Artiva Biotherapeutics is a clinical-stage biotechnology company dedicated to developing off-the-shelf, allogeneic natural killer (NK) cell-based therapies. The company focuses on harnessing the innate immune system to treat patients with autoimmune diseases and cancers, aiming to provide safer, more accessible, and community-ready treatment options.
By utilizing donor-derived NK cells, Artiva seeks to overcome the logistical and manufacturing complexities associated with autologous (patient-specific) cell therapies. Their lead candidate, AlloNK, is currently being evaluated in clinical trials for various autoimmune conditions, including refractory rheumatoid arthritis, with a focus on enhancing the efficacy of B-cell targeted monoclonal antibodies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2019
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Investors:RA Capital Management, Venrock Healthcare Capital Partners, Cormorant Asset Management, EcoR1 Capital, Franklin Templeton
STOCK
Exchange:NASDAQ
Ticker:ARTV
Market Cap:$0.46B
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 3 (Planned)
Modalities:Cell therapy, NK cell therapy
Active Trials:3
Trial Phases:Phase 2: 3
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:GC Cell (Strategic partnership for NK cell manufacturing technology)
COMPETITION
Position:Emerging
Competitors:Kyverna Therapeutics, IGM Biosciences
LEADERSHIP
Key Executives:
Fred Aslan - CEO
Diego Miralles - President and Head of R&D
Jennifer Bush - COO
Scientific Founders:Peter Flynn
Board Members:Brian F. Daniels, Elaine Sorg, Alison Moore, Daniel G. Baker, Laura Stoppel
LINKS
Website:artivabio.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Artiva Biotherapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.